p4b GmbH

p4b GmbH is an Austrian biotechnology startup founded in 2023 that specializes in digital and 3D-printed technologies for bioprocessing. The company provides solutions designed to facilitate process scale-up and optimization by bridging the gap between laboratory innovation and industrial production. Their core offerings include the pDS system, which utilizes 3D-printed bioreactor inserts to replicate large-scale conditions at the bench scale, and digital simulation tools like DREAM-bio, which employs computational fluid dynamics (CFD) to identify optimal bioreactor geometries and improve performance metrics such as mixing and shear stress. By integrating biotechnology expertise with software development, p4b enables clients to de-risk scale-up processes early in development.

These technologies are designed to help bioprocessing partners identify unknown challenges, reduce scale-up costs, and accelerate development timelines without requiring extensive prior process knowledge or large datasets. The company's product-agnostic approach allows for implementation within existing workflows, providing actionable insights that help optimize bioprocess design from the bench to production scale. By enabling more efficient and reliable scale-up, p4b supports organizations in achieving higher efficiency and robust performance in their biopharmaceutical production and research activities.